EDESA BIOTECH, INC. Grants Receivable, Current
EDESA BIOTECH, INC. (EDSA) had Grants Receivable, Current of $0 as of 2014-08-31, per its 10-K filed 2014-11-21.
Discontinued › Notes › Nontrade Receivables › Nontrade Receivables, Current
us-gaap:GrantsReceivableCurrent · last filed 2014-11-21
- 2014-08-31: Grants Receivable, Current $0.00.
- 2013-08-31: Grants Receivable, Current $157.30K.
| Period end | Grants Receivable, Current |
|---|---|
| 2014-08-31 | $0.00 10-K · filed 2014-11-21 |
| 2013-08-31 | $157.30K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |